rs145191476
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_013296.5(GPSM2):c.1661C>A(p.Ser554*) variant causes a stop gained change. The variant allele was found at a frequency of 0.000151 in 1,613,562 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_013296.5 stop_gained
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_013296.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GPSM2 | NM_013296.5 | MANE Select | c.1661C>A | p.Ser554* | stop_gained | Exon 14 of 15 | NP_037428.3 | ||
| GPSM2 | NM_001321038.2 | c.1661C>A | p.Ser554* | stop_gained | Exon 14 of 15 | NP_001307967.1 | |||
| GPSM2 | NM_001321039.3 | c.1661C>A | p.Ser554* | stop_gained | Exon 14 of 16 | NP_001307968.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GPSM2 | ENST00000264126.9 | TSL:1 MANE Select | c.1661C>A | p.Ser554* | stop_gained | Exon 14 of 15 | ENSP00000264126.3 | ||
| GPSM2 | ENST00000674914.1 | c.1712C>A | p.Ser571* | stop_gained | Exon 15 of 16 | ENSP00000501579.1 | |||
| GPSM2 | ENST00000675087.1 | c.1712C>A | p.Ser571* | stop_gained | Exon 16 of 17 | ENSP00000502020.1 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152040Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000677 AC: 17AN: 251184 AF XY: 0.0000810 show subpopulations
GnomAD4 exome AF: 0.000161 AC: 235AN: 1461522Hom.: 0 Cov.: 31 AF XY: 0.000158 AC XY: 115AN XY: 727106 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000592 AC: 9AN: 152040Hom.: 0 Cov.: 32 AF XY: 0.0000539 AC XY: 4AN XY: 74250 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Chudley-McCullough syndrome Pathogenic:2Other:1
Variant interpreted as Pathogenic and reported on 06-26-2017 by Invitae. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information.
PVS1, PM2
not provided Pathogenic:2
This sequence change creates a premature translational stop signal (p.Ser554*) in the GPSM2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GPSM2 are known to be pathogenic (PMID: 22578326, 22987632). This variant is present in population databases (rs145191476, gnomAD 0.02%). This premature translational stop signal has been observed in individuals with Chudley-McCullough syndrome (PMID: 22578326). ClinVar contains an entry for this variant (Variation ID: 35493). For these reasons, this variant has been classified as Pathogenic.
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at a significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 27064331, 23494849, 22578326, 27180139, 34313030)
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at